85 results for: Innovation and Invention
Photograph
Women working at Genetic Systems lab, Redmond, July 15, 1991
In 1980, New York stockbroker David Blech and his brother Isaac partnered with Dr. Robert Nowinski of the Fred Hutchinson Cancer Research Center in Seattle to start Genetic Systems, focused on producing antibodies to diagnose diseases. The Blech brothers raised $40 million in start-up costs, and the company went public in 1981. Bristol-Myers Squibb acquired the company, Seattle's first major…
ID Number:2000.107.073.47.01
Date:1991
Photograph
Tom Gibbs and Molly Boone checking water monitoring system, Seattle, August 31, 1963
Charles V. "Tom" Gibbs (1932-2019) was an engineer whose historic projects in the 1960s ended the constant flow of raw sewage into Lake Washington and Puget Sound. Born in Oregon and raised in Winlock, Washington, Mr. Gibbs received civil engineering degrees in 1954 and 1966 from the University of Washington (UW). He and his wife, Jean C. Gibbs, later endowed…
ID Number:2000.107.074.15.01
Date:1963
Photograph
Bruce Mosley working on gene cloning at Immunex, Seattle, October 11, 1983
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.03
Date:1983
Photograph
Dace Krasts working in lab at Immunex, Seattle, July 23, 1992
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.04
Date:1992
Photograph
Noel Balantac working in lab at Immunex, Seattle, December 12, 1989
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.05
Date:1989
Photograph
Dace Krasts working in lab at Immunex, Seattle, December 13, 1990
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.06
Date:1990
Photograph
Immunex manufacturing and development center, Bothell, October 15, 1992
Scientists Steven Gillis and Christopher Henney, along with businessman Stephen Duzan, founded Immunex in July 1981. They envisioned the company's mission as developing, producing, and licensing diagnostic and therapeutic immunological products. Its successful drugs included LEUKINE (sargramostin) for patients undergoing bone marrow transplants, NOVANTRONE for multiple sclerosis, and ENBREL (etanercept), an anti-inflammatory used to treat arthritis. By 2001 Immunex was…
ID Number:2000.107.095.22.07
Date:1992
Photograph
Product technician inspecting package at IMRE Corporation lab, Seattle, March 1, 1993
IMRE Corporation, one of Seattle's pioneering biotechnology companies, was founded in 1981, and went public in 1983. Their major product, the Prosorba Column, invented by CEO Frank R. Jones, filters immune complexes from blood plasma to treat some immune diseases, and was the first device of its kind to receive FDA approval, granted in 1987. The company rebranded as Cypress…
ID Number:2000.107.095.22.08
Date:1993
Photograph
Dave Walter, Jeremy Jaech, and Ted Johnson meeting about Axon, Seattle, October 19, 1990
Three former Aldus executives (Jeremy Jaech, Dave Walter, and Ted Johnson) established Axon Corporation in Seattle in 1990, to create business graphics software for use on personal computers. Later known as Visio Corporation, they created the design product Visio, which became Microsoft Visio when Microsoft bought the company in 2000. Both Jaech and Johnson would continue to work on the…
ID Number:2000.107.097.39.01
Date:1990
Photograph
Gordon Letwin, lead designer for systems software at Microsoft, Redmond, December 1986
In 1986, Microsoft was developing new software to take advantage of Intel’s recently released 80836 microchip, which was significantly faster and more powerful than previous chips. Companies had already begun building computer hardware with the new chips, but there was not yet an operating system or other software specifically designed for them. As the developer of the MS-DOS operating system…
ID Number:2000.107.112.29.01
Date:1986